Hanna Kumpulainen is Kasve’s founder, who currently works in background as a partner and senior advisor.
Hanna is professional in Quality Management Systems and strategy work and has over 15 years experience in leadership, strategic development and development of Quality Management Systems in different kind of organizations. She is liked trainer in the above mentioned topics.
Hanna is also a yoga teacher and interested in personal growth and communication between people. She focuses on keeping balance between different sectors in life. She enjoys reading, practising yoga and walking in the nature.
Riitta Vartiainen is currently one of our Senior Advisors and her versatile know-how and experience supports well Kasve’s team and its key activities. Riitta is also Kasve’s co-owner.
Riitta is an experienced Board professional, and Mentor: board membership experience since 2011 in several Finnish start-up companies (health technology/medical devices, drug development, expert services). Riitta was a Kasve Board member during 2013-2020, and also a Chairman of the Board during 2015-2018.
Riitta Vartiainen has more than 30 years’ pharma industry experience (including a long career at Orion Corporation) and also several years’ experience in health technology and medical devices. Riitta Vartiainen was a Member of Orion Corporation Executive Management Board during 2006-2010. Her position was Senior Vice President / Business development and Support (Global business development incl. licensing arrangements and alliance management, Mergers & acquisitions, Business Intelligence, Health Economics, Medical affairs, Project Management).
PhD Jouni Sirviö, Founder, CEO and Senior expert of Oy Sauloner Ltd, is highly skilled specialist in research, discovery and early development processes for proprietary pharmaceuticals, CRO research services, and diagnostic medical devices businesses segments, and having a specialist focus on CNS core therapy areas. The knowledge and know-how have been acquired during two-decade academic and industrial career, and applied as an entrepreneur longer than 10 years.
Juhani Lahdenperä has worked over 15 years in the biotechnology business – last ten years as a start-up CEO or Operations Manager. He has been responsible for the day-to-day management of operations, fundraising and business development activities in his recent positions. He has also participated to basic research activities during his career and has published altogether five articles, one in Nature. Juhani has been awarded by Venture Cup and Nordic Center of Excellence in Disease Genetics.
Tom Ståhlberg is a highly experienced regulatory expert in medical devices and in vitro diagnostics, and during his long career has worked e.g. in PerkinElmer as Director of Regulatory Affairs and in Healthtech Finland as Regulatory Expert. After retiring from Healthtech Finland, Tom has offered his expertise to industry through his own company, RaLex Partners. Tom is also a very good trainer and he can communicate regulatory challenges and industry specifics in a very understandable way.
Tom works as Kasve’s Senior Advisor and expert, especially in matters related to Qaira’s development. Tom’s impressive expertise is, of course, also available to our customers.
Janne Karjalainen is one of the founders of Bone Index Finland Oy, which has brought medical device technology to the market for osteoporosis diagnostics. Janne holds a doctorate in medical physics and has experience in commercialising research and international clinical validation of a medical device. In addition, Janne has solid experience in product marketing, medical device product development, substitutability, regulatory requirements (EU and USA).
Janne works as Kasven’s Senior Advisor, especially in projects aimed at the USA market.
Dr. Ilkka Juuso, DSc, has a doctorate in technology from the University of Oulu and 20+ years of experience working on R&D projects in both industry and academia. He is one of the founders of the medical device startup Cerenion, and its Chief Operations Officer and Quality Manager. Ilkka brings this experience to Kasve as a Senior Advisor influencing, for example, the development of the novel QAiRA-tool.
Ilkka’s main interests are international regulatory affairs (incl. EU MDD/MDR and US FDA), ISO 13485 quality management and medical-grade software development. Marketing and business strategy are also always close to his heart. At Cerenion Ilkka has led the development of an ISO 13485, ISO 14971 and IEC 62304 compliant Quality Management System (QMS) from the ground up, its subsequent day-to-day operation, and certification by a notified body.
He has also had a key role in the development and launch of a CE-marked Class IIb medical device under the Medical Device Directive (93/42/EEC) of the European Union. Ilkka has a deep involvement in quality and regulatory affairs, including participation in international standardization activities concerning e.g. quality management, healthcare software, artificial intelligence, and both lifecycle and agile methods in software development.
In his spare time Ilkka has reviewed some 3000+ films, developed a small technology company with his university colleagues, designed his family home and generally enjoyed family life.